Keyphrases
Arginase-1 (Arg-1)
100%
Synergize
100%
Anticancer Immunity
100%
Anti-PD-1
100%
PD-1 Blockade
100%
Immune Modulatory Vaccine
100%
Tumor
30%
Myeloid Cells
20%
Syngeneic Mouse Model
20%
Immune Response
10%
Monotherapy
10%
Cancer Patients
10%
Derived Peptide
10%
Vaccination
10%
Peptide Vaccine
10%
Epitope
10%
Peripheral Blood
10%
Antigen-specific
10%
Antitumor Effect
10%
Flow Cytometric Analysis
10%
Tumor Microenvironment
10%
T Cell Infiltration
10%
Increased Activity
10%
Arginine
10%
Tumor Control
10%
Immune Regulation
10%
Antitumor Efficacy
10%
Therapeutic Vaccine
10%
T Cell Immunity
10%
Systemic Toxicity
10%
Immunosuppressive Mechanisms
10%
Immunosurveillance
10%
ELISpot Assay
10%
Tumor Immunity
10%
Targeted Therapeutics
10%
Clinical Translation
10%
Cell Composition
10%
Immunotherapeutic Approaches
10%
Combinational Therapy
10%
Checkpoint Blockade
10%
Suppressive Function
10%
Targeted Immunotherapy
10%
Inflammatory Microenvironment
10%
Immunosuppressive Microenvironment
10%
Aggressive Phenotype
10%
Tumor-infiltrating Macrophages
10%
Immunology and Microbiology
Vaccine Efficacy
100%
Tumor Immunity
100%
Mouse
66%
Myeloid
66%
Syngenic
66%
Immunosuppressive Drug
66%
Immune Response
33%
Normal Human
33%
T Cell
33%
Vaccination Policy
33%
Adoptive Immunity
33%
Epitope
33%
Antigen Specificity
33%
Immunotherapy
33%
Cell Infiltration
33%
Tumor-Associated Macrophage
33%
Immunosurveillance
33%
Enzyme-Linked Immunospot Assay
33%
Cell Composition
33%
Peptide Vaccine
33%